VORICONAZOLE-GX voriconazole 50mg tablet blister pack

Maa: Australia

Kieli: englanti

Lähde: Department of Health (Therapeutic Goods Administration)

Aktiivinen ainesosa:

voriconazole, Quantity: 50 mg

Saatavilla:

Medis Pharma Pty Ltd

INN (Kansainvälinen yleisnimi):

Voriconazole

Lääkemuoto:

Tablet, film coated

Koostumus:

Excipient Ingredients: microcrystalline cellulose; croscarmellose sodium; lactose monohydrate; magnesium stearate; povidone; titanium dioxide; hypromellose; triacetin; macrogol 3350

Antoreitti:

Oral

Kpl paketissa:

2, 56, 10, 14, 28, 20, 30, 100, 50

Prescription tyyppi:

(S4) Prescription Only Medicine

Käyttöaiheet:

VORICONAZOLE-GX is indicated for treatment of the following fungal infections:,Invasive aspergillosis.,Serious Candida infections (including C. krusei), including oesophageal and systemic Candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,Serious fungal infections caused by Scedosporium spp and Fusarium spp.,Other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,Prophylaxis in patients who are at high risk of developing invasive fungal infections. The indication is based on studies including patients undergoing haematopoietic stem cell transplantation. This brand is only available as tablets and therefore only indicated for adults and children 12 years or older who can tolerate tablets.

Tuoteyhteenveto:

Visual Identification: white, round biconvex tablets, debossed 'VC50' on one side and plain on the reverse'; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Valtuutuksen tilan:

Licence status A

Valtuutus päivämäärä:

2015-02-02